Predict your next investment

HEALTHCARE | Drug Discovery

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$2.1M

Last Raised

$2.1M | 13 yrs ago

About Xori

XORI Corp. is a development stage company focused on a technology for the rapid discovery and development of therapeutic monoclonal antibodies for oncology, immune disorders and infectious disease.

Xori Headquarter Location

1616 Eastlake Ave. E. Suite 205

Seattle, Washington, 98102,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Xori

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Xori is included in 2 Expert Collections, including Cancer.

C

Cancer

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

818 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.